China’s Amended Patent Law Could Facilitate Compulsory Licenses Of Pharmaceuticals – Patent Attorneys
This article was originally published in PharmAsia News
Executive Summary
BEIJING - Leaders of China's national legislature are currently reviewing amendments to the patent law that could make it easier to force global pharmaceutical firms to license drugs to Chinese competitors in the event of a public health crisis